Global Leader in Generic and Biosimilar Medicines: Susana Almeida Appointed as General Secretary – IGBA

2024-01-22 17:20:00

The International Association for Generic and Biosimilar Medicines (TERM), representative of the manufacturers of these drugs around the world, has announced the appointment of Susana Almeida as the new general secretary of the organization.

After 20 years of contribution to the role of organizations and companies in the European and international pharmaceutical industry of generic medicines and biosimilars, Almeida also contributes its extensive experience in the process of international harmonization of standards through the International Conference on Harmonization of Technical Requirements for the Registry of Pharmaceutical Products for Human Use (ICH).

Susana Almeida’s career

Before joining the IGBA, Almeida has been director of Clinical Development and Safety at the employer’s association. Medicines for Europe. Also has worked in clinical trials and pharmacovigilance in Europe and North America, and his experience includes the pharmaceutical industry and clinical research organizations. She has a doctorate in Clinical Pharmacology from the Faculty of Medicine of the Autonomous University of Barcelona (UAB), and is the author of several scientific articles.

“I firmly believe that the mGeneric and biosimilar medications play a fundamental role in order to promote patient access to quality drugs at a sustainable cost. I look forward to working with IGBA members to make our voices heard. A strong off-patent medicines sector is essential for a healthy medicines ecosystem,” said Susana Almeida.

For its part, Adrian van den Hovengeneral director of Medicines for Europe and president of the IGBA, has stated: “Susana Almeida joins the IGBA in a crucial moment for access to medicines. His extensive international experience in the regulatory, political and business spheres will help the generic and biosimilar medicines sector achieve its essential public health mission in collaboration with our stakeholders. “I look forward to working with her to drive much-needed reforms in medicines policies around the world.”

Although it may contain statements, data or notes from health institutions or professionals, the information contained in Medical Writing is edited and prepared by journalists. We recommend the reader that any health-related questions be consulted with a healthcare professional.

1705992461
#Susana #Almeida #general #secretary #IGBA

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.